<DOC>
	<DOCNO>NCT01011062</DOCNO>
	<brief_summary>The study aim investigate effect acute angiotensin receptor blockade insulin action/insulin resistance expression select adipocytokines subcutaneous adipose tissue insulin-resistant subject type 2 diabetes healthy control . Hypothesis : Changes adipocytokine concentration and/or expression different reaction acute vivo induce hyperinsulinemia angiotensin receptor blockade find patient type 2 diabetes compare healthy subject . A significant relationship insulin sensitivity select adipokines intracellular fat content high energy phosphate soleus muscle document healthy individual , significant relation find patient type 2 diabetes .</brief_summary>
	<brief_title>Effect Angiotensin Receptor Blockade Insulin Resistance Adipose Tissue Cytokines Type 2 Diabetes</brief_title>
	<detailed_description>10-15 patient type 2 diabetes 10-15 healthy control subject examine outpatient basis . The following examination carry subject 12 hr fasting : - Oral glucose tolerance test ( 75 g glucose ) ( healthy subject confirm normal tolerance glucose ) . - Evaluation insulin secretion 1 mg glucagon i.v . - Hyperinsulinaemic ( 75 milly-international unit ( mIU ) /l ) euglycemic clamp study last 4 hour combine indirect calorimetry biopsy subcutaneous adipose tissue . - Hyperinsulinemic ( 75 mIU/l ) euglycemic clamp study last 4 hour combine indirect calorimetry losartan 100 mg give even morning study . - Proton phosphorus magnetic resonance spectroscopy . Before ( 0 min ) , 30 min end study c ) ) blood sample take biopsy subcutaneous abdominal adipose tissue do .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>1 . Type 2 Diabetes treat oral agent and/or diet 2 . Healthy volunteer age sexmatched type 2 diabetes , without concomitant disease 1 . Type 2 Diabetes treat insulin clinical evidence atherosclerotic complication advance longterm diabetic complication ( manifest nephropathy , proliferative retinopathy ) internal disease weight change &gt; 10 % 3 month prior study 2 . Healthy volunteer fulfil criterion metabolic syndrome weight change &gt; 10 % 3 month prior study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Adipose tissue</keyword>
	<keyword>Adipokines</keyword>
</DOC>